Delivery Order SPE2DB20D3103-SPE2DB24FQ0Q9

Award Date 8/27/24
Potential Completion Date 8/28/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,814.63 firm fixed-price delivery order is for the provision of TADLIQ 20 MG/5 ML SUSPENSION 150ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. There is no set-aside designation associated...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,219.11 to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of TADLIQ 20 MG/5 ML SUSPENSION 150ML, a pharmaceutical product, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...
The U.S. government's Defense Logistics Agency (DLA) awarded a $44,661.78 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through July 3, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $3,708 firm-fixed-price delivery order contract (SPE2DX22D0029|SPE2D825F17GN) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, covers the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen also holds a larger $999,999,999 Indefinite Delivery Contract...
The U.S. government's Defense Logistics Agency (DLA) awarded a $1,346.66 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, covers the supply of a variety of pharmaceutical products, medical supplies, and equipment to support military healthcare programs. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $8,244.65 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, covers the procurement of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and vials. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government's Defense Logistics Agency (DLA) awarded a $1,723.68 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a period of performance through March 2025, is for the provision of various pharmaceutical products and medical supplies to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
The U.S. government's Defense Logistics Agency (DLA) awarded a $3,092.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, supports the DLA Troop Support Medical program with the delivery of various pharmaceutical products, medical supplies, and equipment through February 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a $13,627.38 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC enables the company to provide a comprehensive range of pharmaceutical products and medical supplies, including...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $36,444.14 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, supports the supply of a range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ0Q9
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $3,657.33 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of "4565602636 ! TADLIQ 20 MG/5 ML SUSPENSION 150ML". This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs. These contract vehicles enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:33 PM